# Vera Therapeutics, Inc.: Form 8-K, filed May 26, 2026

- Company: [Vera Therapeutics, Inc.](/companies/vera.md) (CIK 1831828)
- Form: 8-K
- Filed: 2026-05-26
- Accepted by EDGAR: May 26, 2026, 16:54 ET
- Period: 2026-05-21
- Accession: 0001193125-26-239559
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1831828/000119312526239559/vera-20260521.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1831828/000119312526239559/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1831828/000119312526239559/vera-20260521.htm

Filed May 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-239559. Last ingested by Listed: Nov 5, 2026, 17:26 ET. No prices; not investment advice.